Paclitaxel-platinum combination chemotherapy for advanced or recurrent ovarian clear cell adenocarcinoma: a multicenter trial
- 24 January 2006
- journal article
- research article
- Published by Elsevier in International Journal of Gynecologic Cancer
- Vol. 16 (1) , 52-56
- https://doi.org/10.1111/j.1525-1438.2006.00289.x
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trialThe Lancet, 2003
- Retrospective Analysis of Carboplatin and Paclitaxel as Initial Second-Line Therapy for Recurrent Epithelial Ovarian Carcinoma: Application Toward a Dynamic Disease State Model of Ovarian CancerJournal of Clinical Oncology, 2002
- Prognostic Factors of Stage IV Epithelial Ovarian Cancer: A Multicenter Retrospective StudyGynecologic Oncology, 2001
- Clinical characteristics of clear cell carcinoma of the ovaryCancer, 2000
- Lack of improved survival plus increase in thromboembolic complications in patients with clear cell carcinoma of the ovary treated with platinum versus nonplatinum-based chemotherapyCancer, 1996
- Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian CancerNew England Journal of Medicine, 1996
- Long-Term Survival in Advanced Ovarian Cancer after Cytoreduction and Chemotherapy TreatmentGynecologic Oncology, 1994
- Clear Cell Epithelial Ovarian Cancer (Mesonephroid): Bad Prognosis Only in Early StagesGynecologic Oncology, 1993
- Clear cell carcinoma of the ovary: A study of 59 casesGynecologic Oncology, 1989
- Ovarian clear cell adenocarcinomaGynecologic Oncology, 1989